Anonymous
Guest
Anonymous
Guest
Complete BS - The facts are as follows - On the RX side Flat to declining IMS numbers even with new product introductions. Your are now ranked as the 6th company IMS sales in Derm. not a top derm company as you all advertise. You are not adding head count in the field and all one has to do is look at what is going on with your Aesthetic portfolio to see what a mess that has become. You are only replacing reps and mangers in the field not adding head count. If you are in fact adding head count it is in the home office and or support positions and that my friend is what got this company into a complete mess in the first place. Adding overhead and more internal head count is not growth. All one has to do is look at the market place and that my dear is not growing. The numbers do not lie.
One of the reasons the Rx side is flat and declining is due to Managed Care. In my territory this year alone we have lost two preferred positions and plans are utilizing generics 1st line. We are sliding in the rankings as the competition is becoming more aggressive in managed care. We do not need these distractions if we are suppose to grow in a very competitive market. Should be interesting year on the Rx side.